Skip to main content
Log in

A one-step fully automated radio-synthesis of a dopamine transporter PET imaging agent 18F-FECNT and its in vivo evaluations

  • Published:
Journal of Radioanalytical and Nuclear Chemistry Aims and scope Submit manuscript

Abstract

2β-Carbomethoxy-3β-(4-chlorophenyl)-8-(2-[18F]fluoroethyl)nortropane ([18F]-FECNT) is a potential dopamine transporter PET imaging agent. However, its current radio-synthesis is tedious and time consuming. In this article, we reported a fully automatic method for the synthesis of [18F] FECNT through only one step, using a TRACERlab FXN module, with decay corrected radiochemical yield of 25 ± 5 % (n = 5). The total synthesis time was 50–55 min. The synthesized [18F]FECNT was evaluated in vivo in Parkinson’s disease model rats.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Scheme 1
Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Muller L, Halldin C, Lundkvist C et al (1996) Development of radioligads for the dopamine transporter. J Radioanal Nucl Chem 206:133–144

    Google Scholar 

  2. Laakso A, Bergman J, Haaparanta M et al (1998) [18F] CFT [[18F] WIN35,428], a radioligand to study the dopamine transporter with PET: characterization in human subject. Synapse 28:244–250

    Article  CAS  Google Scholar 

  3. Halldin C, Erixon-Lindroth N, Pauli S et al (2003) [11C]PE2I: a highly selective radioligand for PET examination of the dopamine transporter in monkey and human brain. Eur J Nucl Med Mol Imaging 30:1220–1230

    Article  CAS  Google Scholar 

  4. Davis MR, Votaw JR, Bremner JD et al (2003) Initial human PET imaging studies with the dopamine transporter ligand 18F-FECNT. J Nucl Med 44:855–861

    CAS  Google Scholar 

  5. Winogrodzka A, Bergmans P, Booij J et al (2003) [123I]beta-CIT SPECT is a useful method for monitoring dopaminergic degeneration in early stage Parkonson’s disease. J Neurol Neurosurg Psychiatry 74:294–298

    Article  CAS  Google Scholar 

  6. Kim HJ, Im JH, Yang SO et al (1997) Imaging and quantitation of dopamine transporters with iodine-123-IPT in normalo and Parkinson’s disease subjects. J Nucl Med 38:1703–1711

    CAS  Google Scholar 

  7. Ma Y, Dhawan V, Mentis M et al (2002) Parametric mapping of [18F]FPCIT binding in early stage Parkonson’s disease: a PET study. Synapse 45:125–133

    Article  CAS  Google Scholar 

  8. Kazumata K, Dhawan V, Chaly T et al (1998) Dopamine transporter imaging with fluorine-18-FPCIT and PET. J Nucl Med 39:1521–1530

    CAS  Google Scholar 

  9. Robeson W, Dhawan V, Belakhlef A et al (2003) Dosimetry of the dopamine transprter radioligand 18F-FPCIT in human subjects. J Nucl Med 44:961–966

    CAS  Google Scholar 

  10. Chaly T, Dhawan V, Kazumata K et al (1996) Radiosynthesis of [18F]N-3-fluoropropyl-2-beta-carbomethoxy-3-beta-(4-iodophenyl)nortropane and the first human study with positron emission tomography. Nucl Med Biol 23:999–1004

    Article  CAS  Google Scholar 

  11. Goodman MM, Keil R, Shoup TM et al (1997) Fluorine-18 FPCIT: a PET radiotracer for imaging dopamine transporters. J Nucl Med 38:119–126

    CAS  Google Scholar 

  12. Lundkvist C, Halldin C, Ginovart N et al (1997) [18F]beta-CIT-FP is superior to [11C]beta-CIT-FP for quantitation of the dopamine transporter. Nucl Med Biol 24:621–627

    Article  CAS  Google Scholar 

  13. Lundkvist C, Halldin C, Swahn CG et al (1995) [O-methyl-11C]beta-CIT-FP, a potential radioligand for quantitation of the dopamine transprter: preparation, autoradiography, metabolite studies, and positron emission tomography examinations. Nucl Med Biol 22:905–913

    Article  CAS  Google Scholar 

  14. Chen ZP, Wang SP, Tang J et al (2008) Simplified method for determining radiochemical purity of 99mTc-TRODAT-1. J Radioanal Nucl Chem 277:591–594

    Article  CAS  Google Scholar 

  15. Voll RJ, McConathy J, Waldrep MS et al (2005) Semi-automated preparation of the dopamine transporter ligand [18F]FECNT for human PET imaging studies. Appl Radiat Isot 63:353–361

    Article  CAS  Google Scholar 

  16. Goodman MM, Kilts CD, Keil R, Shi B et al (2000) 18F-labeled FECNT: a selective radioligand for PET imaging of brain dopamine transporter. Nucl Med Biol 27(1):1–12

    Google Scholar 

  17. Chin ET, McCarron JA, Musachio JL, Hong J et al (2003) A ‘ONE-POT’ synthesis of 18F-FECNT and its implementation in a commercial automated radiosynthesis apparatus. J Label Compd Radiopharm 26:S215

    Google Scholar 

  18. Voll RJ, McConathy J, Waldrep MS, Crowe RJ, Goodman MM (2005) Semiautomated preparation of the dopamine transporter ligand [18F]FECNT for human PET imaging studies. Appl Radiat Isot 63(3):353–361

    Article  CAS  Google Scholar 

  19. Chen ZP, Wang SP, Li XM et al (2008) A one-step automated high-radiochemical-yield synthesis of 18F-FECNT from mesylate precursor. Appl Radiat Isot 66:1881–1885

    Article  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by China National Natural Science Foundation (81000622, 30970844 and 81071181).

Conflict of interest

The authors certify that all the affiliations with, or financial involvement in, any organization or entity with a financial interests in or financial conflict with the subject matter of materials discussed in the manuscript are completely disclosed.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hui Wang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Liang, S., Chen, Z., Ma, Y. et al. A one-step fully automated radio-synthesis of a dopamine transporter PET imaging agent 18F-FECNT and its in vivo evaluations. J Radioanal Nucl Chem 298, 1969–1972 (2013). https://doi.org/10.1007/s10967-013-2672-y

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10967-013-2672-y

Keywords

Navigation